Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1056 | 1090 | 1125 | 1338 | 1372 | 1802 |
Fund Return | 5.58% | 8.97% | 12.55% | 10.18% | 6.53% | 6.06% |
Place in category | 487 | 534 | 448 | 262 | 749 | 298 |
% in Category | 37 | 42 | 36 | 25 | 75 | 47 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Acatis Gane Value Event Fonds UI B | 6.43B | 8.66 | 4.65 | 6.98 | ||
Acatis Gane Value Event Fonds UI C | 6.43B | 8.31 | 3.85 | 6.39 | ||
Acatis Gane Value Event Fonds UI A | 6.43B | 8.32 | 4.22 | 6.54 | ||
ACATIS Datini Valueflex Fonds A | 735.7M | 5.47 | -2.14 | 11.21 | ||
ACATIS Datini Valueflex Fonds B | 735.7M | 4.81 | -2.97 | 10.39 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
UniEuroAktien | 2.37B | 4.94 | 7.58 | 6.09 | ||
Basler-Aktienfonds DWS | 478.8M | 5.14 | 3.04 | 4.60 | ||
Allianz Wachstum Euroland A EUR | 312.91M | 7.19 | 1.00 | 6.71 | ||
Allianz Wachstum Euroland IT2 EUR | 2.71M | 7.34 | 1.87 | 7.43 | ||
LBBW Dividenden Strategie Eurolandr | 302.11M | 2.18 | 5.74 | 2.59 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
ASML Holding | NL0010273215 | 7.22 | 618.20 | -1.42% | |
Sanofi | FR0000120578 | 4.71 | 97.70 | -1.01% | |
Hermes International | FR0000052292 | 3.93 | 2,071.00 | -0.48% | |
Louis Vuitton | FR0000121014 | 3.86 | 606.70 | -0.70% | |
L'Oreal | FR0000120321 | 3.84 | 344.40 | -0.61% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Neutral | Buy |
Technical Indicators | Sell | Sell | Strong Buy |
Summary | Strong Sell | Neutral | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review